quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:11:03·737d
SECFiling
Advaxis, Inc. logo

SEC Form 10-K filed by Advaxis, Inc.

ADXS· Advaxis, Inc.
Health Care
Original source

Companies

  • ADXS
    Advaxis, Inc.
    Health Care

Related

  • PR449d
    OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostrate Cancer Programs to Pipeline
  • PR714d
    Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations
  • SEC714d
    SEC Form 15-12G filed by Advaxis, Inc.
  • SEC727d
    SEC Form 10-K/A filed by Advaxis, Inc. (Amendment)
  • SEC734d
    Advaxis, Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)
  • SEC738d
    SEC Form S-8 POS filed by Advaxis, Inc.
  • SEC738d
    SEC Form S-8 POS filed by Advaxis, Inc.
  • SEC738d
    SEC Form S-8 POS filed by Advaxis, Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022